The new therapy has produced dramatic responses in some men with aggressive prostate cancer and who have failed current therapies.
The Big picture…
The Big Picture
.CANCERRESEARCH is a collaborative initiative facilitated by the Australian Cancer Research Foundation. Its focus is to bring together news, information, and leading opinion on cancer treatment, prevention, diagnosis and cure. We want you to be a part of the .CANCERRESEARCH community...
Please click here to learn more.
Types of Cancer
Latest Research News
The Zero Childhood Cancer program has just released initial results of its national clinical trial, revealing promising outcomes within its first 11 months.
This post was originally published on theconversation.com.The human immune system is actually quite good at killing cancer cells. In fact, we believe it does so quite frequently. People who have AIDS or have had an organ transplant have suppressed immune systems and go on to develop cancer more often than healthy individuals. And as people […]
Melbourne scientists have discovered a new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer therapies.
An international team of researchers has used a new scientific method to discover at least 12 new genes that influence the risk of developing breast cancer.
Queensland researchers have developed an online test for people aged 40 and over to predict their risk of developing melanoma over the next 3.5 years
Cancer is still surprising researchers, making the pathway to urgently-needed new treatments more difficult to predict.
Researchers have developed a blood test that can detect the presence of eight common cancers. Called CancerSEEK, the blood test detects tiny amounts of DNA
SYDNEY, NSW — The Australian Cancer Research Foundation (ACRF) has announced $7.5 million in cancer research funding today cutting-edge research technology and infrastructure to speed up discoveries in prevention, diagnosis and treatment of cancer.
A newly approved breast cancer drug could be highly effective against some forms of pancreatic cancer, including metastatic cancer. The study also revealed a new straightforward way to test which patients might respond positively to treatment.
